<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04603638</url>
  </required_header>
  <id_info>
    <org_study_id>2019/1458</org_study_id>
    <nct_id>NCT04603638</nct_id>
  </id_info>
  <brief_title>The Comparison of Analgesia Methods Used for Spinal Surgery</brief_title>
  <official_title>The Comparison of Analgesia Methods Used for Spinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study ; Two randomized groups will be created. Iv magnesium will be given to one of&#xD;
      the blindly designated groups. The other group will be given only isotonic. All patients will&#xD;
      be awakened after the analgesic agents (0,1mg / kg morphine, 15mg / kg paracetamol, nsaid)&#xD;
      are used in routine practice and will be followed up for intensive care.&#xD;
&#xD;
      The use of PCA (patient controlled analgesia) device is available in both groups.In&#xD;
      post-operative period, magnesium infusion will be continued for 12 h. Only 100cc isotonic&#xD;
      will be given without using magnesium to the other group. VAS (visual analog scale) score&#xD;
      will be recorded at postoperative 30. minutes and 2,6,12,18,24 hours. In routine&#xD;
      administration, the patient should be given 2 mg of morphine if vas&gt;4 and the maximum dose&#xD;
      will be increased to 10 mg.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After the approval of the ethics committee for the study, in the Istanbul University Faculty&#xD;
      of Medicine Orthopedics and Traumatology Department; There will be 3 or more posterior&#xD;
      instrumentation operations, cobb angle of 40 degrees and above, 18-75 years old, ASA&#xD;
      (American Society of Anesthesiologists) score 1-3, no chronic neuropathic pain and no&#xD;
      psychiatric illness, no chronic narcotic analgesics and / or substance abuse a creatine value&#xD;
      below 1.3 will be included.&#xD;
&#xD;
      Standard anesthesia monitoring will be performed for patients taken to the operation room.&#xD;
      Routine anesthesia induction will be performed. In the prone position, anesthesia maintenance&#xD;
      will be provided using the infusion of propofol and remifentanil.&#xD;
&#xD;
      Our clinic; PCA (patient-controlled analgesia) device with intravenous morphine is used&#xD;
      routinely for postoperative analgesia.In this study ;two randomized groups will be created.&#xD;
      It will give iv magnesium(in the intraoperative period at a dose of 40mg / kg, within 30&#xD;
      minutes after induction) to a blindly designated group. The other group will be given only&#xD;
      isotonic. After in post-operative period, magnesium infusion will be continued for 12 hours&#xD;
      (40mg / kg). Magnesium sulfate will be given in 100 cc isotonic. In the other group, only&#xD;
      100cc isotonic will be given without using magnesium. All patients will be awakened after the&#xD;
      analgesic agents (0,1mg / kg morphine, 15mg / kg paracetamol, nsaid) are used in routine&#xD;
      practice and will be followed up for intensive care.&#xD;
&#xD;
      The use of PCA device is available in both groups. vas score will be recorded postoperative&#xD;
      30. minutes and 2,6,12,18,24 hours. In routine administration, the patient should be given 2&#xD;
      mg of morphine if vas&gt;4 and the maximum dose will be increased to 10 mg.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 4, 2020</start_date>
  <completion_date type="Anticipated">February 4, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 4, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>The analgesia methods will be compared with morphine consumption</description>
  </primary_outcome>
  <primary_outcome>
    <measure>VAS score</measure>
    <time_frame>24 hours</time_frame>
    <description>The analgesia methods will be compared with VAS score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Analgesia</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>magnesium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>participations will be given intravenous magnesium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>participations will be given intravenous isotonic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium</intervention_name>
    <description>40 mg/kg(peroperative), 40 mg/kg (postoperative 12 h)</description>
    <arm_group_label>magnesium</arm_group_label>
    <other_name>NMDA (n-metil d aspartat) blocker</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isotonic</intervention_name>
    <description>100 ml</description>
    <arm_group_label>control</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 -75 years old&#xD;
&#xD;
          -  Patients with posterior instrumentation surgery of 3 or more levels under general&#xD;
             anesthesia with a cobb angle of 40 degrees and above&#xD;
&#xD;
          -  Patients who will be awakened after the surgery is completed and intensive care&#xD;
             follow-up&#xD;
&#xD;
          -  Patients with ASA classification 1-3&#xD;
&#xD;
          -  Patients with creatine value &lt;1.3 g / dl&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having a history of chronic neuropathic pain&#xD;
&#xD;
          -  Having a psychiatric illness&#xD;
&#xD;
          -  Patients who should not be awakened after surgery but should be followed up intubated&#xD;
             and sedated&#xD;
&#xD;
          -  Patients who cannot provide adequate cooperation for scoring&#xD;
&#xD;
          -  Patients with chronic opioid use and / or substance use&#xD;
&#xD;
          -  Patients with ASA classification&gt; 3&#xD;
&#xD;
          -  Patients with a creatinine value of 1.3 g / dl and higher&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mehmet Ilke Buget</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dilek HUNDUR</last_name>
    <phone>+905367044679</phone>
    <email>dilekhundur@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istanbul University</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dilek HUNDUR</last_name>
      <phone>+905367044679</phone>
      <email>dilekhundur@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Jabbour HJ, Naccache NM, Jawish RJ, Abou Zeid HA, Jabbour KB, Rabbaa-Khabbaz LG, Ghanem IB, Yazbeck PH. Ketamine and magnesium association reduces morphine consumption after scoliosis surgery: prospective randomised double-blind study. Acta Anaesthesiol Scand. 2014 May;58(5):572-9. doi: 10.1111/aas.12304. Epub 2014 Mar 17.</citation>
    <PMID>24635528</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>August 9, 2020</study_first_submitted>
  <study_first_submitted_qc>October 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2020</study_first_posted>
  <last_update_submitted>October 25, 2020</last_update_submitted>
  <last_update_submitted_qc>October 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Dilek Hundur</investigator_full_name>
    <investigator_title>Resident at Anesthesiology and Reanimation</investigator_title>
  </responsible_party>
  <keyword>magnesium</keyword>
  <keyword>morphine</keyword>
  <keyword>scoliosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

